Published on 29/05/2018
Published on 17/04/2018
Published on 26/03/2018
Published on 05/03/2018
Published on 04/12/2017
Âé¶¹ÆÆ½â°æ announces completion and topline data from Phase 2 ALPESTRIA-1 clinical study in Alport syndrome demonstrating Vonafexor reverses kidney function decline and has sustai...